This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laricchia-Robbio, L.
Right arrow Articles by Nucifora, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laricchia-Robbio, L.
Right arrow Articles by Nucifora, G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2006, p. 7658-7666, Vol. 26, No. 20
0270-7306/06/$08.00+0     doi:10.1128/MCB.00363-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Point Mutations in Two EVI1 Zn Fingers Abolish EVI1-GATA1 Interaction and Allow Erythroid Differentiation of Murine Bone Marrow Cells{triangledown}

Leopoldo Laricchia-Robbio, Raffaella Fazzina, Donglan Li, Ciro R. Rinaldi, Kisaly K. Sinha, Soumen Chakraborty, and Giuseppina Nucifora*

Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612

Received 28 February 2006/ Returned for modification 1 April 2006/ Accepted 28 July 2006

EVI1 is an aggressive nuclear oncoprotein deregulated by recurring chromosomal abnormalities in myelodysplastic syndrome (MDS). The expression of the corresponding gene is a very poor prognostic marker for MDS patients and is associated with severe defects of the erythroid lineage. We have recently shown that the constitutive expression of EVI1 in murine bone marrow results in a fatal disease with features characteristic of MDS, including anemia, dyserythropoiesis, and dysmegakaryopoiesis. These lineages are regulated by the DNA-binding transcription factor GATA1. EVI1 has two zinc finger domains containing seven motifs at the N terminus and three motifs at the C terminus. Supported by results of assays utilizing synthetic DNA promoters, it was earlier proposed that erythroid-lineage repression by EVI1 is based on the ability of this protein to compete with GATA1 for DNA-binding sites, resulting in repression of gene activation by GATA1. Here, however, we show that EVI1 is unable to bind to classic GATA1 sites. To understand the mechanism utilized by EVI1 to repress erythropoiesis, we used a combination of biochemical assays, mutation analyses, and in vitro bone marrow differentiation. The results indicate that EVI1 interacts directly with the GATA1 protein rather than the DNA sequence. We further show that this protein-protein interaction blocks efficient recognition or binding to DNA by GATA1. Point mutations that disrupt the geometry of two zinc fingers of EVI1 abolish the protein-protein interaction, leading to normal erythroid differentiation of normal murine bone marrow in vitro.

* Corresponding author. Mailing address: University of Illinois at Chicago (M/C 737), 909 South Wolcott Avenue, Chicago, IL 60612. Phone: (312) 413-4686. Fax: (312) 413-0548. E-mail: nucifora{at}uic.edu.

{triangledown} Published ahead of print on 5 September 2006.

Molecular and Cellular Biology, October 2006, p. 7658-7666, Vol. 26, No. 20
0270-7306/06/$08.00+0     doi:10.1128/MCB.00363-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Konrad, T. A., Karger, A., Hackl, H., Schwarzinger, I., Herbacek, I., Wieser, R. (2009). Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes. J. Leukoc. Biol. 86: 813-822 [Abstract] [Full Text]  
  • Laricchia-Robbio, L., Premanand, K., Rinaldi, C. R., Nucifora, G. (2009). EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function. Cancer Res. 69: 1633-1642 [Abstract] [Full Text]  
  • Matsubara, E., Sakai, I., Yamanouchi, J., Fujiwara, H., Yakushijin, Y., Hato, T., Shigemoto, K., Yasukawa, M. (2009). The Role of Zinc Finger Protein 521/Early Hematopoietic Zinc Finger Protein in Erythroid Cell Differentiation. J. Biol. Chem. 284: 3480-3487 [Abstract] [Full Text]  
  • Lugthart, S., van Drunen, E., van Norden, Y., van Hoven, A., Erpelinck, C. A. J., Valk, P. J. M., Beverloo, H. B., Lowenberg, B., Delwel, R. (2008). High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 111: 4329-4337 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»